Opentrons Labworks Inc. has raised $40.0M in Series E funding, with backing from Avego, BroadOak Capital Partners, SoftBank Investment Advisers, Khosla Ventures, Sands Capital and Lerer Hippeau.
The company runs two business units: Opentrons Robotics, which makes liquid handling lab robots used in thousands of institutions across more than 40 countries, and Neochromosome, which works on genome-scale cell engineering for biopharma and biotech.








.png&w=3840&q=75)






